Back
First Citizens BancShares Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
44
FCNCA
First Citizens BancShares
Last Price:
1,679.35
Seasonality Move:
2.42%
Buy
53
SRPT
Sarepta Therapeutics
Last Price:
158.06
Seasonality Move:
18.65%
Sell
44
First Citizens BancShares (FCNCA)
is a Sell
Is First Citizens BancShares a Buy, Sell or Hold?
- The current First Citizens BancShares [FCNCA] share price is $1,651.02. The Score for FCNCA is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- FCNCA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $156.91. The Score for SRPT is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FCNCA Stock Price Chart
What is First Citizens BancShares's stock price today?
-
The First Citizens BancShares share price today is $1,651.02
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FCNCA is experiencing buying pressure, which is a positive indicator for future bullish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $156.91
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
FCNCA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -17.81 | Sell |
| Relative Strength Index (14 RSI): | 44.45 | Sell |
| Chaikin Money Flow: | 52395 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1639.41 - 1739.75) | Sell |
| Bollinger Bands (100): | (1537.99 - 1709.37) | Buy |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.17 | Buy |
| Relative Strength Index (14 RSI): | 68.43 | Buy |
| Chaikin Money Flow: | 1613298 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (113.82 - 142.64) | Buy |
| Bollinger Bands (100): | (118.8 - 136.1) | Buy |
FCNCA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1643.4 | Buy |
| 20-day SMA: | 1668.71 | Sell |
| 50-day SMA: | 1690.32 | Sell |
| 200-day SMA: | 1512.91 | Buy |
| 8-day EMA: | 1647.63 | Buy |
| 20-day EMA: | 1666.81 | Sell |
| 50-day EMA: | 1667.38 | Sell |
| 200-day EMA: | 1516.83 | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 140.03 | Buy |
| 20-day SMA: | 129.22 | Buy |
| 50-day SMA: | 127.95 | Buy |
| 200-day SMA: | 115.45 | Buy |
| 8-day EMA: | 145.32 | Buy |
| 20-day EMA: | 134.79 | Buy |
| 50-day EMA: | 129.39 | Buy |
| 200-day EMA: | 120.67 | Buy |
First Citizens BancShares Earnings Growth & FCNCA Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.83 per share, a decrease next quarter of $0.43 per share, an increase this year of $12.55 per share, and an increase next year of $5.79 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.18 per share, an increase next quarter of $2.65 per share, an increase this year of $6.58 per share, and an increase next year of $8.28 per share.
First Citizens BancShares Technical Analysis
| Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics Technical Analysis
| Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||